Androgens play a pivotal role in maintaining penile tissue architecture and erection: A review

Journal of Andrology

Volumn 30, Issue 4, 2009, Pages 363-369

  Traish, Abdulmaged M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipogenesis; Androgen deficiency; Andropause; Corpus cavernosum; Erectile dysfunction; Hormone; Penis; Sexual dysfunction; Smooth muscle

Indexed keywords

ANDROGEN;

ADIPOGENESIS; ANDROGEN DEFICIENCY; ANDROPAUSE; CASTRATION; CONFERENCE PAPER; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; SEXUAL DYSFUNCTION;

ADIPOCYTES; ANDROGENS; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; ERECTILE DYSFUNCTION; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; PENILE ERECTION; PENIS; PLURIPOTENT STEM CELLS;

EID: 68549087113     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.108.006007     Document Type: Conference Paper

References (76)

1. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M, Ouchi Y. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res. 2007;30:1029-1034.
2. Akkus E, Carrier S, Baba K, Hsu GL, Padma-Nathan H, Nunes L, Lue TF. Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence. Br J Urol. 1997;79:47-53. (Pubitemid 28318844)
3. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75:191-236.
4. Armagan A, Hatsushi K, Toselli P. The effects of testosterone deficiency on the structural integrity of the penile dorsal nerve in the rat. Int J Impot Res. 2007;20:73-78.
5. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003;58:632-638. (Pubitemid 36566807)
6. Baba K, Yajima M, Carrier S, Akkus E, Reman J, Nunes L, Lue TF, Iwamoto T. Effect of testosterone on the number of NADPH diaphorase-stained nerve fibers in the rat corpus cavernosum and dorsal nerve. Urology. 2000a;56:533-538. (Pubitemid 30658203)
7. Baba K, Yajima M, Carrier S, Morgan DM, Nunes L, Lue TF, Iwamoto T. Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibers and the erectile response in rat penis. BJU Int. 2000b;85:953-958. (Pubitemid 30242806)
8. Bhasin S, Taylor WE, Singh R, Artaza J, Sinha-Hikim I, Jasuja R, Choi H, Gonzalez-Cadavid NF. The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol. 2003;58:M1103-M1110. (Pubitemid 38018524)
9. Bivalacqua TJ, Musicki B, Usta MF, Champion HC, Kadowitz PJ, Burnett AL, Hellstrom WJ. Endothelial nitric oxide synthase gene therapy for erectile dysfunction. Curr Pharm Des. 2005;11:4059-4067. (Pubitemid 41672477)
10. Bivalacqua TJ, Rajasekaran M, Champion HC, Wang R, Sikka SC, Kadowitz PJ, Hellstrom WJ. The influence of castration on pharmacologically induced penile erection in the cat. J Androl. 1998;19:551-557. (Pubitemid 28498445)
11. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl. 2003;24(6 suppl):S17-S37.
12. Foresta C, Caretta N, Lana A, De Toni L, Biagioli A, Ferlin A, Garolla A. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metab. 2006;91:4599-4602. (Pubitemid 44833444)
13. Foresta C, Zuccarello D, De Toni L, Garolla A, Caretta N, Ferlin A. Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clin Endocrinol (Oxf). 2008;68:284-289.
14. Gentile V, Modesti A, La Pera G, Vasaturo F, Modica A, Prigiotti G, Di Silverio F, Scarpa S. Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction. J Androl. 1996;17:96-103. (Pubitemid 26131752)
15. Giuliano F, Tostain J, Rossi D. Testosterone and male sexuality: basic research and clinical data. Prog Urol. 2004;14:783-790. (Pubitemid 40068773)
16. Goyal HO, Braden TD, Cooke PS, Szewczykowski MA, Williams CS, Dalvi P, Williams JW. Estrogen receptor alpha mediates estrogen-inducible abnormalities in the developing penis. Reproduction. 2007a;133:1057-1067. (Pubitemid 47162595)
17. Goyal HO, Braden TD, Williams CS, Dalvi P, Mansour M, Williams JW. Estrogen-induced abnormal accumulation of fat cells in the rat penis and associated loss of fertility depends upon estrogen exposure during critical period of penile development. Toxicol Sci. 2005a;87:242-254. (Pubitemid 41222677)
18. Goyal HO, Braden TD, Williams CS, Dalvi P, Mansour MM, Williams JW. Permanent induction of morphological abnormalities in the penis and penile skeletal muscles in adult rats treated neonatally with diethylstilbestrol or estradiol valerate: a dose-response study. J Androl. 2005b;26:32-43. (Pubitemid 39665273)
19. Goyal HO, Braden TD, Williams CS, Williams JW. Role of estrogen in induction of penile dysmorphogenesis: a review. Reproduction. 2007b;134:199-208.
20. Guay AT. Relation of endothelial cell function to erectile dysfunction: implications for treatment. Am J Cardiol. 2005;96:52M-56M.
21. Guay AT. ED2: erectile dysfunction = endothelial dysfunction. Endocrinol Metab Clin N Am. 2007;36:453-463.
22. Haggestrom S, Lissbrant IF, Bergh A, Damber JE. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol. 1999;161:1620-1625. (Pubitemid 29420852)
23. Hatzichristou DG, Hatzimouratidis K, Apostolidis A, Ioannidis E, Yannakoyorgos K, Kalinderis A. Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test. Eur Urol. 1999;36:60-67.
24. Hatzichristou DG, Saenz de Tejada I, Kupferman S, Namburi S, Pescatori ES, Udelson D, Goldstein I. In vivo assessment of trabecular smooth muscle tone, its application in pharmacocavernosometry and analysis of intracavernous pressure determinants. J Urol. 1995;153:1126-1135.
25. Heaton JP, Varrin SJ. Effects of castration and exogenous testosterone supplementation in an animal model of penile erection. J Urol. 1994;151:797-800.
26. Hwang TI, Chen HE, Tsai TF, Lin YC. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. Int J Impot Res. 2006;18:400-404.
27. Jevtich M, Khawand NY, Vidic B. Clinical significance of ultrastructural findings in the corpus cavernosa of normal and impotent men. J Urol. 1990;143:289-293.
28. Keast JR, Gleeson RJ, Shulkes A, Morris MJ. Maturational and maintenance effects of testosterone on terminal axon density and neuropeptide expression in the rat vas deferens. Neuroscience. 2002;112:391-398. (Pubitemid 34607022)
29. Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Pioglitazone prevents corporal veno-occlusive dysfunction in a rat model of type 2 diabetes mellitus. BJU Int. 2006;98:116-124. (Pubitemid 43885518)
30. Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. N Engl J Med. 1989;321:1648-1659.
31. Kurbatov D, Kuznetsky J, Traish A. Testosterone improves erectile function in hypogonadal patients with venous leakage. J Androl. 2008a;29(6):630-637.
32. Kurbatov DG, Kuznetsky YY, Kitaev SV, Brusensky VA. Magnetic resonance imaging as a potential tool for objective visualization of venous leakage in patients with veno-occlusive erectile dysfunction. Int J Impot Res. 2008b;20:192-198.
33. Lu YL, Kuang L, Zhu H, Wu H, Wang XF, Pang YP, Wang NJ, Yu DL. Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5alpha-reductase inhibitor. Asian J Androl. 2007;9:843-847. (Pubitemid 350090508)
34. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829-836.
35. Mersdorf A, Goldsmith PC, Diederichs W, Padula CA, Lue TF, Fishman IJ, Tanagho EA. Ultrastructural changes in impotent penile tissue: a comparison of 65 patients. J Urol. 1991;145:749-758.
36. Meusburger SM, Keast JR. Testosterone and nerve growth factor have distinct but interacting effects on structure and neurotransmitter expression of adult pelvic ganglion cells in vitro. Neuroscience. 2001;108:331-340.
37. Mills TM, Stopper VS, Wiedmeier VT. Effects of castration and androgen replacement on the hemodynamics of penile erection in the rat. Biol Reprod. 1994;51:234-238. (Pubitemid 24220931)
38. Moon DG, Lee KC, Kim YW, Park HS, Cho HY, Kim JJ. Effect of TCDD on corpus cavernosum histology and smooth muscle physiology. Int J Impot Res. 2004;16:224-230. (Pubitemid 38858953)
39. Moon DG, Sung DJ, Kim YS, Cheon J, Kim JJ. Bisphenol A inhibits penile erection via alteration of histology in the rabbit. Int J Impot Res. 2001;13:309-316. (Pubitemid 33054623)
40. Moreland RB. Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism. Int J Impot Res. 2000;12(suppl 4):S39-S46.
41. Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, Payton TR, Krane RJ, Goldstein I. Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J Urol. 1997;158:1752-1758. (Pubitemid 27433146)
42. Mulhall JP, Anderson M, Parker M. Congruence between venoocclusive parameters during dynamic infusion cavernosometry: assessing the need for cavernosography. Int J Impot Res. 2004;16:146-149. (Pubitemid 38579460)
43. Müller SC, Hsieh JT, Lue TF, Tanagho EA. Castration and erection. An animal study. Eur Urol. 1988;15(1-2):118-124.
44. Musicki B, Burnett AL. Endothelial dysfunction in diabetic erectile dysfunction. Int J Impot Res. 2007;19:129-1138.
45. Natoli AK, Medley TL, Ahimastos AA, Drew BG, Thearle DJ, Dilley RJ, Kingwell BA. Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension. 2005;46:1129-1134.
46. Nehra A, Azadzoi KM, Moreland RB, Pabby A, Siroky MB, Krane RJ, Goldstein I, Udelson D. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol. 1998;159:2229-2236. (Pubitemid 29190812)
47. Nehra A, Goldstein I, Pabby A, Nugent M, Huang YH, de las Morenas A, Krane RJ, Udelson D, Saenz de Tejada I, Moreland RB. Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J Urol. 1996;156:1320-1329.
48. Palese MA, Crone JK, Burnett AL. A castrated mouse model of erectile dysfunction. J Androl. 2003;24:699-1703.
49. Persson C, Diederichs W, Lue TF, Yen TSB, Fishman IJ, Mclin P, Tanagho EA. Correlation of altered penile ultrastructure with clinical arterial evaluation. J Urol. 1989;142:1462-1468. (Pubitemid 20011957)
50. Rajfer J, Rosciszewski A, Mehringer M. Prevalence of corporeal venous leakage in impotent men. J Urol. 1988;140:69-71. (Pubitemid 18189116)
51. Rogers RS, Graziottin TM, Lin CM, Kan YW, Lue T. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res. 2003;15:26-37. (Pubitemid 36356356)
52. Saenz de Tejada I. Molecular mechanisms for the regulation of penile smooth muscle contractility. Int J Impot Res. 2002;14(suppl 1):S6-S10. (Pubitemid 34215244)
53. Saenz de Tejada I, Carson MP, de las Morenas A, Goldstein I, Traish AM. Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Am J Physiol. 1991a;261(4 pt 2):H1078-H1085.
54. Saenz de Tejada I, Moroukian P, Tessier J, Kim JJ, Goldstein I, Frohrib D. Trabecular smooth muscle modulates the capacitor function of the penis. Studies on a rabbit model Am J Physiol, 1991b;260(5 pt 2):H1590-H1595.
55. Shabsigh R, Raymond JF, Olsson CA, O'Toole K, Buttyan R. Androgen induction of DNA synthesis in the rat penis. Urology. 1998;52:723-728. (Pubitemid 28440192)
56. Shen ZJ, Zhou XL, Lu YL, Chen ZD. Effect of androgen deprivation on penile ultrastructure. Asian J Androl. 2003;5:33-36.
57. Simpson S, Marshal FHA. On the effects of stimulating the nervi erigentes in castrated animals. Q J Exp Physiol. 1908;1:257-259.
58. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology. 2006;147:141-154. (Pubitemid 43004269)
59. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipo-genesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology. 2003;144:5081-5088. (Pubitemid 37378423)
60. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89:251-253. (Pubitemid 36241528)
61. Suzuki N, Sato Y, Hisasue S, Kato R, Suzuki K, Tsukamoto T. Effect of testosterone on intracavernous pressure elicited with electrical stimulation of the medial preoptic area and cavernous nerve in male rats. J Androl. 2007;28:218-222. (Pubitemid 46423902)
62. Takahashi Y, Hirata Y, Yokoyama S, Ishii N, Nunes L, Lue TF, Tanagho EA. Loss of penile erectile response to intracavernous injection of acetylcholine in castrated dog. Tohoku J Exp Med. 1991;163:85-91.
63. Traish A, Kim N. The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med.. 2005;2:759-770. (Pubitemid 41727389)
64. Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol. 2007;52:54-70. (Pubitemid 46803026)
65. Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med. 2006;3:382-404.
66. Traish AM, Munarriz R, O'Connell L, Choi S, Kim SW, Kim NN, Huang YH, Goldstein I. Effects of medical and surgical castration on erectile function in an animal model. J Androl. 2003;24:381-387. (Pubitemid 39571794)
67. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology. 1999;140:1861-1868. (Pubitemid 29149259)
68. Traish AM, Toselli P, Jeong SJ, Kim NN. Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl. 2005;26:242-248. (Pubitemid 40293710)
69. Udelson D, Nehra A, Hatzichristou DG, Azadzoi K, Moreland RB, Krane RJ, Saenz de Tejada I, Goldstein I. Engineering analysis of penile hemodynamic and structural-dynamic relationships: part III-clinical considerations of penile hemodynamic and rigidity erectile responses. Int J Impot Res. 1998;10:89-99. (Pubitemid 28286826)
70. Watts GF, Chew KK, Stuckey BG. The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention. Nat Clin Pract Cardiovasc Med. 2007;4:263-273. (Pubitemid 46672115)
71. Wespes E, Goes PM, Schiffmann S, Deprierreux M, Vanderhaeghen JJ, Schulman CC. Computerized analysis of smooth muscle fibers in potent and impotent patients. J Urol. 1991;146:1015-1017.
72. Wespes E, Raviv G, Vanegas JP, Decaestecker C, Petein M, Danguy A, Schulman CC, Kiss R. Corporeal veno-occlusive dysfunction: a distal arterial pathology? J Urol. 1998;160:2054-2057.
73. Wespes E, Rammal A, Garbar C. Sildenafil non-responders: haemodynamic and morphometric studies. Eur Urol. 2005;48:136-139. (Pubitemid 40835609)
74. Wespes E, Sattar AA, Golzarian J, Wery D, Daoud N, Schulman CC. Corporeal veno-occlusive dysfunction: predominantly intracavernous muscular pathology. J Urol. 1997;157:1678-1680. (Pubitemid 27171752)
75. Wespes E, Schiffmann S, Depierreux M, Vanderhaegan JJ, Schulman CC. Is cavernovenous leakage related to a reduction of intracavernous smooth muscle fibers? Int J Impot Res. 1990;2:30.
76. Yassin AA, Saad F, Traish A. Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: a series of case reports. J Sex Med. 2006;3:727-735. (Pubitemid 43919028)